Clinical And Experimental Health Sciences
期刊中文名：臨床和實驗(yan)健康科學ISSN：2459-1459
該雜志(zhi)國際簡稱(cheng)：CLIN EXP HEALTH SCI，是一本致力于發(fa)(fa)布--研(yan)究(jiu)新成果的(de)(de)的(de)(de)專(zhuan)業(ye)(ye)學(xue)(xue)術期刊(kan)(kan)。主要(yao)發(fa)(fa)表刊(kan)(kan)登(deng)有創見(jian)的(de)(de)學(xue)(xue)術論(lun)文文章、行業(ye)(ye)最(zui)(zui)新科研(yan)成果，扼要(yao)報道階段性研(yan)究(jiu)成果和(he)重要(yao)研(yan)究(jiu)工作的(de)(de)最(zui)(zui)新進展，選(xuan)載(zai)對(dui)學(xue)(xue)科發(fa)(fa)展起指導作用的(de)(de)綜述與專(zhuan)論(lun)，促進學(xue)(xue)術發(fa)(fa)展，為廣大讀者服務。該刊(kan)(kan)是一本國際優秀雜志(zhi)，在國際上有很(hen)高的(de)(de)學(xue)(xue)術影響(xiang)力。
雜志介紹
Clinical And Experimental Health Sciences雜志介紹
《Clinical And Experimental Health Sciences》是一本(ben)(ben)以English為主的(de)(de)未開放獲取國(guo)際優秀期刊(kan)，中文名(ming)稱臨(lin)床和實(shi)驗健(jian)康科學(xue)，本(ben)(ben)刊(kan)主要出版、報道領域的(de)(de)研(yan)究動態以及在該(gai)領域取得(de)的(de)(de)各方(fang)面的(de)(de)經驗和科研(yan)成果，介紹(shao)該(gai)領域有關(guan)本(ben)(ben)專(zhuan)業(ye)的(de)(de)最(zui)新(xin)進展(zhan)，探討行業(ye)發(fa)展(zhan)的(de)(de)思路和方(fang)法，以促進學(xue)術信息交流，提高(gao)行業(ye)發(fa)展(zhan)。該(gai)刊(kan)已被國(guo)際權威(wei)數據庫(ku)SCIE收錄，為該(gai)領域相關(guan)學(xue)科的(de)(de)發(fa)展(zhan)起到了良好的(de)(de)推動作用，也得(de)到了本(ben)(ben)專(zhuan)業(ye)人員的(de)(de)廣泛認可。該(gai)刊(kan)最(zui)新(xin)影(ying)響因子為0.3，
英文介紹
Clinical And Experimental Health Sciences雜志英文介紹
Clinical and Experimental Health Sciences is a comprehensive medical academic journal that focuses on research in clinical medicine and experimental health sciences. This journal aims to provide a platform for researchers, clinical doctors, scholars, and students in the medical field to exchange and share the latest research findings, clinical practices, and experimental discoveries. It covers a wide range of medical fields, including but not limited to internal medicine, surgery, pediatrics, obstetrics and gynecology, neuroscience, oncology, immunology, pharmacology, public health, and epidemiology.
The magazine is committed to publishing high-quality research papers that have undergone peer review, typically including original research, review articles, case reports, clinical trial results, technical method introductions, and expert reviews. Through these contents, readers can learn about the latest research trends in the medical field, innovative methods in clinical practice, and cutting-edge advances in experimental science. The target readership of the magazine includes clinical doctors, medical researchers, public health experts, medical students, and other professionals interested in medicine. By providing an authoritative academic exchange platform, this journal helps strengthen connections and collaborations within the global medical community, promoting the dissemination and application of medical knowledge.
JCR分區（2023-2024年最新版）
Clinical And Experimental Health Sciences雜志 JCR分區信息
| 按JIF指(zhi)標學科分區 |
學科：MEDICINE, RESEARCH & EXPERIMENTAL
收錄子集：ESCI
分區：Q4
排名：179 / 189
百分位：
5.6% |
| 按JCI指標(biao)學科(ke)分區(qu) |
學科：MEDICINE, RESEARCH & EXPERIMENTAL
收錄子集：ESCI
分區：Q4
排名：179 / 189
百分位：
5.56% |
JCR分區：JCR分(fen)(fen)(fen)(fen)區(qu)來自科(ke)睿唯安(an)公司,JCR是一個(ge)獨特的(de)多學科(ke)期(qi)(qi)(qi)(qi)刊(kan)(kan)評價工具，為唯一提供基于(yu)引文數據(ju)的(de)統計信息的(de)期(qi)(qi)(qi)(qi)刊(kan)(kan)評價資(zi)源。每年(nian)發(fa)布的(de)JCR分(fen)(fen)(fen)(fen)區(qu)，設置了(le)254個(ge)具體學科(ke)。JCR分(fen)(fen)(fen)(fen)區(qu)根據(ju)每個(ge)學科(ke)分(fen)(fen)(fen)(fen)類(lei)按照期(qi)(qi)(qi)(qi)刊(kan)(kan)當年(nian)的(de)影響(xiang)因子高低將期(qi)(qi)(qi)(qi)刊(kan)(kan)平均分(fen)(fen)(fen)(fen)為4個(ge)區(qu)，分(fen)(fen)(fen)(fen)別為Q1、Q2、Q3和Q4，各占25%。JCR分(fen)(fen)(fen)(fen)區(qu)中期(qi)(qi)(qi)(qi)刊(kan)(kan)的(de)數量是均勻分(fen)(fen)(fen)(fen)為四個(ge)部分(fen)(fen)(fen)(fen)的(de)。
CiteScore 評價數據（2024年最(zui)新(xin)版）
Clinical And Experimental Health Sciences雜志CiteScore 評價數據
歷年影響因子和期刊自引率
投稿經驗
Clinical And Experimental Health Sciences雜志投稿經驗
該雜(za)(za)志(zhi)是一本國(guo)際優(you)秀(xiu)雜(za)(za)志(zhi)，在國(guo)際上有較高的學(xue)(xue)術(shu)影響力，行(xing)業關注度很(hen)(hen)高，已被(bei)國(guo)際權(quan)威數據庫SCIE收錄，該雜(za)(za)志(zhi)在綜(zong)合(he)專業領域專業度認可很(hen)(hen)高，對(dui)稿(gao)(gao)件(jian)內容的創新性(xing)和學(xue)(xue)術(shu)性(xing)要(yao)(yao)求很(hen)(hen)高，作為一本國(guo)際優(you)秀(xiu)雜(za)(za)志(zhi)，一般投(tou)稿(gao)(gao)過(guo)審時(shi)間(jian)(jian)都較長，投(tou)稿(gao)(gao)過(guo)審時(shi)間(jian)(jian)平(ping)均 ，如果想投(tou)稿(gao)(gao)該刊(kan)要(yao)(yao)做好時(shi)間(jian)(jian)安排。版面費不祥。該雜(za)(za)志(zhi)近兩年(nian)未(wei)被(bei)列入預警名單，建議您投(tou)稿(gao)(gao)。如您想了解更多(duo)投(tou)稿(gao)(gao)政策及投(tou)稿(gao)(gao)方案，請咨詢客服(fu)。
免責聲明
若(ruo)用戶(hu)需要出版服務，請(qing)聯系出版商(shang)。